MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on ...
TARPON SPRINGS, Fla., April 21, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib ...
NEW HAVEN, Conn., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) today announced that three posters for vepdegestrant, including clinical data, will be presented at the 2024 San ...
‒ Poster for GP2 Phase IIb clinical trial final efficacy analysis was presented during the 2020 San Antonio Breast Cancer Symposium (SABCS) today ‒ Phase IIb clinical trial was a prospective, ...
Posters from the American Association of Cancer Research (AACR) Annual Meeting demonstrated the use of genomic profiling and sequencing can detect immunotherapy biomarkers and predict clinical ...
Retinoblastoma (RB) is an eye cancer in children. It’s a deadly, fast-growing disease, making early detection critical. British charity the Childhood Eye Cancer Trust (CHECT) and agency Wunderman ...
Oral and poster presentations span three priority programs in breast, gynecologic, and gastrointestinal cancers, advancing ...
Can you tell us about the imaging technique at the core of this poster? We are using multiplex fluorescence imaging, staining with 10 different antibodies on a single slide. To achieve this level of ...
Speakers elaborated on health care delivery and regulatory policy posters presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. This article will appear in the ASCO recap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results